Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target

Investing.comTuesday, September 30, 2025 at 7:24:56 AM
Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target
Jefferies has maintained a Hold rating on Aurinia Pharmaceuticals, setting a price target of $10 for the stock. This decision reflects the firm's cautious outlook on the company's performance, indicating that while there may be potential, investors should be mindful of the risks involved. This news is significant as it provides insight into the market's perception of Aurinia's future, which could influence investor decisions.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Top Japan Pharma Stocks to Watch: Jefferies Highlights Buying Opportunities
PositiveFinancial Markets
Jefferies has identified promising buying opportunities in the Japanese pharmaceutical sector, highlighting several stocks that are poised for growth. This is significant as it suggests a positive outlook for investors looking to capitalize on the potential of Japan's innovative drug market, especially in a time when global healthcare is evolving rapidly.
Quest Diagnostics at Jefferies 2025: Strategic Growth and Market Expansion
PositiveFinancial Markets
Quest Diagnostics recently presented at the Jefferies 2025 conference, highlighting its strategic growth plans and market expansion initiatives. This is significant as it showcases the company's commitment to enhancing healthcare services and adapting to market demands, which could lead to improved patient outcomes and increased shareholder value.
Jefferies’ quarterly profit beats estimate as dealmaking rebound drives record advisory fees
PositiveFinancial Markets
Jefferies has reported a quarterly profit that surpasses estimates, driven by a significant rebound in dealmaking activities which has led to record advisory fees. This is an important development as it highlights the recovery of the financial sector and suggests increased confidence among businesses to engage in mergers and acquisitions. Such growth not only benefits Jefferies but also signals a positive trend for the broader economy.
Jefferies Q3 results top estimates, as advisory sales climb on increased M&A boom
PositiveFinancial Markets
Jefferies has reported impressive Q3 results that exceeded analysts' expectations, driven by a surge in advisory sales amid a booming mergers and acquisitions (M&A) market. This growth highlights the firm's strong position in the financial sector and reflects broader trends in corporate activity, making it a significant indicator of economic health and investor confidence.
RadNet at Jefferies Conference: Strategic Growth in Imaging
PositiveFinancial Markets
RadNet recently presented at the Jefferies Conference, highlighting its strategic growth in the imaging sector. This is significant as it showcases the company's commitment to expanding its services and improving patient care through advanced imaging technologies. Investors and stakeholders are likely to view this positively, as it indicates a forward-thinking approach and potential for increased market share.
Jefferies downgrades Moonlake Immunotherapeutics stock rating to Hold on disappointing trial results
NegativeFinancial Markets
Jefferies has downgraded the stock rating of Moonlake Immunotherapeutics to 'Hold' following disappointing results from a recent trial. This decision reflects concerns about the company's future prospects and investor confidence. Such downgrades can significantly impact stock prices and investor sentiment, making it crucial for stakeholders to stay informed about the company's developments.
CSX stock price target raised to $40 from $38 at Jefferies on strong momentum
PositiveFinancial Markets
CSX's stock price target has been raised to $40 from $38 by Jefferies, reflecting strong momentum in the company's performance. This adjustment indicates confidence in CSX's growth potential and could attract more investors, highlighting the company's positive trajectory in the market.
Aurinia Pharmaceuticals stock hits 52-week high at 13.45 USD
PositiveFinancial Markets
Aurinia Pharmaceuticals has reached a significant milestone as its stock hit a 52-week high of 13.45 USD. This achievement reflects growing investor confidence in the company's potential and its recent developments in the pharmaceutical sector. Such a rise in stock price is crucial as it not only boosts the company's market valuation but also enhances its ability to attract further investments and support ongoing research and development efforts.
Jefferies raises Enphase Energy stock price target to $41 on improving residential outlook
PositiveFinancial Markets
Jefferies has raised its price target for Enphase Energy's stock to $41, reflecting a positive outlook for the residential energy market. This adjustment is significant as it indicates confidence in the company's growth potential and the increasing demand for renewable energy solutions. Investors may see this as a strong signal to consider Enphase Energy as a viable option in their portfolios.
Jefferies reiterates Buy rating on Carnival stock, maintains $31 price target
PositiveFinancial Markets
Jefferies has reaffirmed its Buy rating on Carnival stock, setting a price target of $31. This endorsement reflects confidence in Carnival's recovery and growth potential, especially as the cruise industry continues to rebound post-pandemic. Investors may find this news encouraging as it suggests a positive outlook for the company's future performance.
Jefferies cuts Tryg to “hold” on slower growth, trims price target to DKK169
NegativeFinancial Markets
Jefferies has downgraded Tryg to a 'hold' rating, citing concerns over slower growth prospects. This decision also comes with a reduced price target of DKK169, reflecting a more cautious outlook on the company's performance. This matters because it signals potential challenges for Tryg in the competitive insurance market, which could impact investor confidence and stock performance.
Jefferies initiates Atour Lifestyle stock with Buy rating on retail growth
PositiveFinancial Markets
Jefferies has initiated coverage of Atour Lifestyle with a Buy rating, highlighting the company's strong potential for growth in the retail sector. This endorsement is significant as it reflects confidence in Atour's business model and market strategy, suggesting that investors may see promising returns as the retail landscape evolves.
Latest from Financial Markets
Third of workforce to go at Lindsey Oil Refinery
NegativeFinancial Markets
The Lindsey Oil Refinery is facing significant workforce cuts, with a third of its employees set to lose their jobs. The Unite union has voiced strong criticism of the government's handling of the situation, arguing that the refinery could remain operational and intact. This news is concerning not only for the workers affected but also for the local economy, as such layoffs can have a ripple effect on the community.
Jobs to go at Lincolnshire oil refinery; UK economy grew faster than thought under Labour – business live
NegativeFinancial Markets
The Lindsey oil refinery in north Lincolnshire is set to lose about 125 jobs due to the collapse of its parent company, Prax Group. This news is concerning as it highlights the vulnerabilities in the energy sector, but there is a glimmer of hope with at least two bids to purchase and operate the refinery, potentially preserving jobs. The situation underscores the ongoing challenges in the UK economy and the importance of stability in the energy industry.
Trump claims a TikTok deal is done. Who would own it, and how would it work?
NeutralFinancial Markets
Former President Trump has announced that a deal regarding TikTok is finalized, although specifics remain unverified by China or ByteDance, the app's owner. This situation is significant as it highlights ongoing tensions between the U.S. and China over technology and data privacy, and the outcome could impact millions of TikTok users and the app's future in the American market.
Investing & Wealth Growth in the USA: A Complete Guide
PositiveFinancial Markets
Investing and wealth growth in the USA is becoming increasingly accessible, thanks to a variety of tools and resources available to individuals. This guide highlights the importance of understanding investment strategies and managing portfolios effectively, which can lead to financial independence and security. As more people engage with investing, it not only benefits their personal finances but also contributes to the overall economic growth of the country.
African Pioneer secures mining license for Namibian copper project
PositiveFinancial Markets
African Pioneer has successfully secured a mining license for its copper project in Namibia, marking a significant step forward for the company and the local economy. This development is crucial as it not only opens up new opportunities for mining in the region but also promises to create jobs and stimulate economic growth. The project is expected to attract investment and enhance Namibia's position in the global copper market.
Tamboran resources secures final investment for Beetaloo gas project
PositiveFinancial Markets
Tamboran Resources has successfully secured the final investment needed for its Beetaloo gas project, marking a significant milestone in the development of this energy initiative. This investment not only boosts the company's prospects but also highlights the growing interest in natural gas as a key energy source in Australia. The Beetaloo project is expected to create jobs and contribute to the local economy, making it an important development for the region.